Evidence map›Paper›PMID 39513149›Full record

ArticleCardiovascular diagnosis and therapy2024

Prevalence and predictors of right ventricular dysfunction among adults living with HIV in northwest Nigeria.

Shehu A Kana, Rukayya S Alkassim, Aishatu L Adamu, Ibrahim Y Ibrahim, Bryan E Shepherd, Mahmoud U Sani, C William Wester, Muktar H Aliyu

Abstract read
In one paragraph

Article in Cardiovascular diagnosis and therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Echocardiography in HIV Disease.Current cardiology reports · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shehu A KanaDepartment of Internal Medicine, Aminu Kano Teaching Hospital, Kano, Nigeria.ORCID https://orcid.org/0000-0002-9361-2684
Rukayya S AlkassimDepartment of Statistics, Aliko Dangote University of Science and Technology, Wudil, Nigeria.
Aishatu L AdamuDepartment of Community Medicine, Aminu Kano Teaching Hospital, Kano, Nigeria.
Ibrahim Y IbrahimDepartment of Mathematics, Bayero University, Kano, Nigeria.
Bryan E ShepherdDepartment of Biostatistics, Vanderbilt University, Nashville, TN, USA.
Mahmoud U SaniDepartment of Medicine, Bayero University & Aminu Kano Teaching Hospital, Kano, Nigeria.
C William WesterVanderbilt Institute of Global Health, Vanderbilt University Medical Centre, Nashville, TN, USA.
Muktar H AliyuVanderbilt Institute of Global Health, Vanderbilt University Medical Centre, Nashville, TN, USA.

Funding

Vanderbilt-Nigeria Building Research Capacity in HIV and Non-communicable Diseases (NCDs) (V-BRCH) 2D43TW011544 · FIC · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Aishatu Adamu, Muktar Hassan Aliyu · 2020 to 2026
$2.1M
Vanderbilt-Nigeria Biostatistics Training Program (VN-BioStat)D43TW012268 · FIC · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Muktar Hassan Aliyu, Nafiu Hussaini · 2022 to 2026
$1.5M
FIC NIH HHS D43 TW011544FIC NIH HHS D43 TW012268
6 · The paper itself

Abstract

Background: People living with the human immunodeficiency virus (PLWH) are at increased risk of cardiovascular diseases. Right ventricular (RV) function has important prognostic value in cardiac pathology, and advances in imaging modalities, such as transthoracic echocardiography have enabled in-depth RV studies. There is, however, a scarcity of multiparameter RV function studies in PLWH in low- and middle-income settings, such as Nigeria. The aim of this study is to determine the prevalence and predictors of RV dysfunction among adult PLWH in northwest Nigeria. Methods: This is a retrospective cross-sectional study conducted between February 1, 2023 and August 31, 2023. We consecutively recruited 330 adults [median age 45 years, interquartile range (IQR), 38 to 52 years, 61% female] attending human immunodeficiency virus (HIV) and general outpatient clinics in a tertiary hospital in northwest Nigeria. They included 110 antiretroviral therapy (ART)-experienced PLWH, 110 ART-naïve PLWH, and 110 age- and sex-matched HIV-negative control subjects. All participants had conventional two-dimensional (2D), tissue Doppler (TDI), and speckle tracking (2D-STE) echocardiography to estimate left ventricular (LV) and RV systolic and diastolic function, peak systolic and diastolic myocardial velocities, RV and LV longitudinal strain, and chamber dimensions. All participants also underwent 12-lead electrocardiography. Multiple linear and Firth's logistic regression modeling were performed to assess for independent predictors of RV myocardial performance index (RVMPI) as a continuous and as a dichotomous variable, respectively. Results: The prevalence of RV dysfunction, as determined by the RVMPI among HIV-positive participants was 14.5% [95% confidence interval (CI): 10.5-19.8%] compared to 0% (95% CI: 0.0-3.4%) for those without HIV. Among participants with HIV, RVMPI was associated with participant age (P<0.001) and left ventricular ejection fraction (LVEF) (P<0.001). Results were similar when RVMPI was dichotomized. The association between RV dysfunction and LVEF was modified by ART status: a 10% decrease in LVEF was associated with an average decrease of 0.08 in RVMPI among participants who were ART-experienced (β=-0.08, P<0.001) but a lesser decrease among those who were ART- naïve (β=-0.03, P=0.14). Conclusions: This study highlights the complexity of RV dysfunction in PLWH and underscores the importance of LVEF and age as key factors influencing the risk of RV dysfunction in PLWH.

Indexed as

antiretroviral therapy (ART)Human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS)Nigerianon-communicable diseasesright ventricular dysfunction (RV dysfunction)

Identifiers

PMID39513149
PMCPMC11538844

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.